comparemela.com

Latest Breaking News On - Jonathan wolleben - Page 1 : comparemela.com

These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results - Ocular Therapeutix (NASDAQ:OCUL)

Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.

Jonathan-wolleben
Pravin-dugel
Tara-bancroft
Ocular-therapeutix-inc
Executive-chairman
Ocular-therapeutix
Investor-day
Market-outperform
Market-perform

Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday - Bruker (NASDAQ:BRKR), Aspen Aerogels (NYSE:ASPN)

U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.

Jonathan-wolleben
Kellogg-co
Bruker-corporation
Carl-icahn
Ramaco-resources-inc
Larimar-therapeutics-inc
Tripadvisor-inc
Earth-brands-inc
Procaps-group
Korro-bio-inc
Jetblue-airways-corporation
Medpace-holdings-inc

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - IPG Photonics (NASDAQ:IPGP)

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.

Kellogg-co
Bruker-corporation
Photonics-corporation
Renalytix-plc
Jonathan-wolleben
Sunpower-corporation
Teradata-corporation
Carl-icahn
Group-limited
Delta-apparel-inc
Cadence-design-systems-inc
Ohmyhome-limited

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of IPG Photonics Corporation (NASDAQ:IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter fin.

Carl-icahn
Jonathan-wolleben
Bionexus-gene-lab-corp
Renalytix-plc
Medicaid-services
Sunshine-biopharma-inc
Cottonmouth-ventures
Janone-inc
Beamr-imaging-ltd
Millennium-group-international-holdings-limited
Group-limited
Wk-kellogg-co

Where M&A could be heading in the obesity drug space

Investors are contemplating where and when the next big obesity drug deal will occur.

Michael-yee
Jonathan-wolleben
Novo-ozempic
Eli-lilly
Versanis-bio
Bristol-myers-squibb
Vipin-garg
Zealand-pharma
Carter-gould
Pfizer
Novo-nordisk
Barclays

vimarsana © 2020. All Rights Reserved.